Leerink Partners upgraded Doximity from Market Perform to Outperform and set a new price target of $90.00 from $60.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/7/2025 | $31.00 → $78.00 | Neutral → Overweight | Piper Sandler |
| 2/7/2025 | $60.00 → $90.00 | Market Perform → Outperform | Leerink Partners |
| 12/20/2024 | $55.00 | Equal-Weight | Stephens |
| 12/4/2024 | $55.00 | Neutral | Mizuho |
| 11/15/2024 | $58.00 | Neutral | Goldman |
| 11/14/2024 | $33.00 → $53.00 | Underweight → Equal-Weight | Morgan Stanley |
| 11/13/2024 | $40.00 → $60.00 | Buy → Hold | Canaccord Genuity |
| 11/8/2024 | $19.00 → $41.00 | Underweight → Equal Weight | Wells Fargo |
4 - Doximity, Inc. (0001516513) (Issuer)
4 - Doximity, Inc. (0001516513) (Issuer)
4 - Doximity, Inc. (0001516513) (Issuer)
SC 13G/A - Doximity, Inc. (0001516513) (Subject)
SC 13G - Doximity, Inc. (0001516513) (Subject)
SC 13G - Doximity, Inc. (0001516513) (Subject)
With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati
Experienced director and executive brings health system and cloud expertise SAN FRANCISCO, Aug. 4, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced the appointment of Phoebe L. Yang to its Board of Directors. Ms. Yang has been General Manager at Amazon Web Services, Healthcare, and a member of the board of directors for CommonSpirit Health, one of the largest U.S. health systems. Ms. Yang is a long-time member of the Council on Foreign Relations, and has served as an appointee in two Presidential Administrations. In 2021, she was named one of Modern Healthcare's Top 100 Most Influential People in Healthcare and one
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced that Anna Bryson, CFO, will present at the Raymond James 46th Annual Institutional Investors Conference on Tuesday, March 4, 2025, at 10:25 a.m. Eastern Time/7:25 a.m. Pacific Time. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and rese
Earns A-level ratings in all categories Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer has been named 2025 Best in KLAS in the Video Conferencing Platforms segment. This is the fourth consecutive year that Doximity has earned the top position. In addition to securing the #1 spot, Doximity received A-level ratings in all categories, including operations, product, relationship, value, culture, and loyalty. These ratings, which are based on live interviews with over 80 health system leaders and their staff, reinforce Doximity's leadership in delivering a reliable, easy-to-use virtual care platform. "We're hono
Total revenues of $168.6 million, up 25% year-over-year Net income growth of 57% and adjusted EBITDA growth of 39% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 third quarter ended December 31, 2024. "We're proud to deliver another quarter of record engagement in Q3, with over 610,000 unique providers using our clinical workflow tools," said Jeff Tangney, co-founder and CEO of Doximity. "Our AI tools grew the fastest last quarter, up 60% over the prior quarter, while our newsfeed surpassed more than one million unique providers." Fiscal 2025 Third Quarter Financial Highlights All com
SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)
144 - Doximity, Inc. (0001516513) (Subject)
SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)
Piper Sandler upgraded Doximity from Neutral to Overweight and set a new price target of $78.00 from $31.00 previously
Leerink Partners upgraded Doximity from Market Perform to Outperform and set a new price target of $90.00 from $60.00 previously
Stephens initiated coverage of Doximity with a rating of Equal-Weight and set a new price target of $55.00
Total revenues of $168.6 million, up 25% year-over-year Net income growth of 57% and adjusted EBITDA growth of 39% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 third quarter ended December 31, 2024. "We're proud to deliver another quarter of record engagement in Q3, with over 610,000 unique providers using our clinical workflow tools," said Jeff Tangney, co-founder and CEO of Doximity. "Our AI tools grew the fastest last quarter, up 60% over the prior quarter, while our newsfeed surpassed more than one million unique providers." Fiscal 2025 Third Quarter Financial Highlights All com
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2024 after market close on February 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inclu
Total revenues of $136.8 million, up 20% year-over-year Net income growth of 44% and adjusted EBITDA growth of 41% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 second quarter ended September 30, 2024. "Our clinical workflow tools saw record use in Q2 with over 600,000 unique active prescribers," said Jeff Tangney, co-founder and CEO of Doximity. "We're proud to help physicians save time, so they can provide better care for their patients." Fiscal 2025 Second Quarter Financial Highlights All comparisons, unless otherwise noted, are to the three months ended September 30, 2023. Revenue: